Envestnet Asset Management Inc Vertex Pharmaceuticals Inc Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 403,068 shares of VRTX stock, worth $187 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

403,068

Previous 415,060 2.89%

Holding current value

$187 Million

Previous $195 Million 3.64%

% of portfolio

0.06%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$460.0 - $505.78 $5.52 Million - $6.07 Million	-11,992 Reduced 2.89%	403,068 $187 Million
Q2 2024 Aug 08, 2024	BUY	$392.81 - $485.53 $4.62 Million - $5.71 Million	11,751 Added 2.91%	415,060 $195 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $3.8 Million - $4.16 Million	-9,320 Reduced 2.26%	403,309 $169 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $392,049 - $469,407	1,143 Added 0.28%	412,629 $168 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $35.6 Million - $38.1 Million	105,232 Added 34.36%	411,486 $143 Million
Q2 2023 Aug 04, 2023	SELL	$314.42 - $351.91 $360 Million - $403 Million	-1,145,620 Reduced 78.91%	306,254 $108 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $331 Million - $377 Million	1,167,674 Added 410.86%	1,451,874 $457 Million
Q4 2022 Feb 07, 2023	BUY	$285.76 - $321.48 $4.22 Million - $4.75 Million	14,768 Added 5.48%	284,200 $82.1 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $3.8 Million - $4.24 Million	13,885 Added 5.43%	269,432 $78 Million
Q2 2022 Aug 03, 2022	SELL	$234.96 - $292.55 $12.3 Million - $15.3 Million	-52,192 Reduced 16.96%	255,547 $72 Million
Q1 2022 May 04, 2022	BUY	$221.42 - $260.97 $8.52 Million - $10 Million	38,499 Added 14.3%	307,739 $80.3 Million
Q4 2021 Feb 04, 2022	BUY	$177.01 - $223.45 $3.69 Million - $4.66 Million	20,854 Added 8.4%	269,240 $59.1 Million
Q3 2021 Oct 07, 2021	BUY	$181.39 - $202.99 $9.73 Million - $10.9 Million	53,642 Added 27.54%	248,386 $45.1 Million
Q2 2021 Aug 04, 2021	SELL	$187.49 - $221.1 $2.61 Million - $3.08 Million	-13,933 Reduced 6.68%	194,744 $39.3 Million
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $4.09 Million - $4.76 Million	19,743 Added 10.45%	208,677 $44.8 Million
Q4 2020 Feb 02, 2021	SELL	$207.01 - $276.09 $22,357 - $29,817	-108 Reduced 0.06%	188,934 $44.7 Million
Q3 2020 Oct 09, 2020	BUY	$255.65 - $303.1 $6.54 Million - $7.76 Million	25,601 Added 15.66%	189,042 $51.4 Million
Q2 2020 Jul 08, 2020	BUY	$225.48 - $295.8 $11.1 Million - $14.5 Million	49,186 Added 43.05%	163,441 $47.4 Million
Q1 2020 Apr 23, 2020	BUY	$199.77 - $247.81 $4.05 Million - $5.03 Million	20,284 Added 21.59%	114,255 $27.2 Million
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $1.1 Million - $1.48 Million	6,621 Added 7.58%	93,971 $20.6 Million
Q3 2019 Oct 17, 2019	BUY	$166.23 - $187.09 $560,527 - $630,867	3,372 Added 4.02%	87,350 $14.8 Million
Q2 2019 Aug 02, 2019	BUY	$164.61 - $190.37 $542,719 - $627,649	3,297 Added 4.09%	83,978 $15.4 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $1.5 Million - $1.78 Million	9,146 Added 12.79%	80,681 $14.8 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $8.93 Million - $11.3 Million	58,803 Added 461.85%	71,535 $11.9 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $2.32 Million - $2.66 Million	-13,821 Reduced 52.05%	12,732 $2.45 Million
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $1.3 Million - $1.51 Million	8,887 Added 50.31%	26,553 $4.51 Million
Q1 2018 May 09, 2018	SELL	$151.6 - $177.13 $2.42 Million - $2.83 Million	-15,954 Reduced 47.45%	17,666 $2.88 Million
Q4 2017 Feb 20, 2018	BUY	$137.28 - $155.55 $188,485 - $213,570	1,373 Added 4.26%	33,620 $5.04 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $1.2 Million - $1.31 Million	8,088 Added 33.48%	32,247 $4.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	24,159	24,159 $3.11 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Vertex Pharmaceuticals Inc Transaction History